Pavel Jansa
9PUBLICATIONS
44CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Mar 13, 2026
Long-Term Treatment with Single-Tablet Combination of Macitentan and Tadalafil in Pulmonary Arterial Hypertension: Results from A DUE and Its Open-Label Period.H James Ford, Kelly M Chin, Fenling Fan
|Aug 18, 2025
Predicting Response to Switching From Phosphodiesterase Type 5 Inhibitor to Riociguat in Patients With Pulmonary Arterial Hypertension: Biomarker and Responder Analysis of the RESPITE and REPLACE Studies.James R Klinger, Hikmet Al-Hiti, Sung-A Chang
|Apr 28, 2025
Long-Term Treatment With Subcutaneous Treprostinil in Patients With Severe Inoperable Chronic Thromboembolic Pulmonary Hypertension in the Multimodal Therapy Era (Data From CTREPH Study Open Label Extension).Pavel Jansa, Roela Sadushi-Kolici, Nika Skoro-Sajer
|Mar 18, 2025
Single-Tablet Combination Therapy of Macitentan/Tadalafil for Patients with Pulmonary Arterial Hypertension: Qualitative Interview Study of the A DUE Phase 3 Trial.Fenling Fan, Stacy Davis, Claire Burbridge
|May 16, 2024
Randomized, Multicenter Study to Assess the Effects of Different Doses of Sildenafil on Mortality in Adults With Pulmonary Arterial Hypertension.Marius M Hoeper, Ralf Ewert, Pavel Jansa
|Aug 23, 2023
The risk profile change in patients with severe chronic thromboembolic pulmonary hypertension treated with subcutaneous treprostinil.Pavel Jansa, Grzegorz Kopeć, Adam Torbicki
Pageof 2
Frequent Collaborators
2 joint publications
Irene M Lang
1 joint publications
Stepan Havranek
1 joint publications
Zdenka Fingrova
1 joint publications
Tomas Skala
1 joint publications
Milan Dusik
1 joint publications
David Ambroz
1 joint publications
Dalibor Klimes
1 joint publications
Martin Hutyra
1 joint publications
Josef Kautzner
1 joint publications
Ales Linhart
